Mona Ashiya bought $5.5M of Shattuck Labs (STTK)
Executed Aug 25 2025, disclosed Sep 3 2025, 8 days later, against a two-business-day limit.
Over the 21 trading sessions from the disclosed entry session (Sep 2 2025), the stock returned +141.4% (delay-adjusted); from the execution session (Aug 25 2025), +156.7%. Derived: entry at the session's open, exit at the close 20 sessions later.
Mona Ashiya (Director) filed 4 Form 4 reports in the past 24 months (1 purchase, 3 sales, 1 filed past the two-business-day deadline), most often in Disc Medicine, Inc. (IRON). Across 1 priced purchase filing, the average 21-session return was +156.7% from execution and +141.4% from disclosure (delay-adjusted; derived). The largest single filing was $16.8M of IRON (310,215 sh across 9 lots, as filed), executed Mar 10 2025.
Healthcare · Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→